Rising Risk of Subsequent Primary Cancers Among US Cancer Survivors, 2000–2021
Cancer Medicine · 2026-04 · 15 (4)
DOI: 10.1002/cam4.71778 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 06.04.2026. Verfasst von Hui G Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Neoplasms, Second Primary, Cancer Survivors, Neoplasms. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background
As cancer survival improves, the population at risk for subsequent primary cancers (SPCs) is growing rapidly. Yet, contemporary trends in SPC incidence remain undercharacterized, limiting the development of targeted surveillance and survivorship strategies.
Objective
To evaluate long‐term trends in SPC risk among US cancer survivors and identify high‐risk subgroups by cancer type and demographic characteristics. Design, Setting, and Participants This retrospective cohort study used data from 17 SEER registries and included over 6 million individuals diagnosed with an index primary cancer between 2000 and 2021. Main Outcomes and Measures Standardized incidence ratios (observed‐to‐expected ratios, OERs) and Cox proportional hazards models were used to assess SPC trends among male and female cancer survivors. Analyses were stratified by cancer site, latency between index and SPC, stage, age, and race/ethnicity.
Results
SPC risk increased substantially from 2000 to 2020. Among men, OERs rose from 0.95 (95% CI = 0.94, 0.97) to 1.75 (95% CI = 1.70, 1.80); among women, from 1.23 (95% CI = 1.21, 1.24) to 1.76 (95% CI = 1.70, 1.83). The highest SPC incidence occurred within 6 months of the index diagnosis. Variations were observed across demographic and cancer‐related characteristics. Conclusions and Relevance The rising burden of SPCs highlights a critical need in survivorship care. These findings support the need for updated, risk‐stratified surveillance protocols and inform national cancer control strategies aimed at reducing long‐term morbidity among survivors. Study Type Cohort study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.
ORCID-Profile: Hui G Cheng, Oxana Palesh, Susan Hong
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Cheng, H. G., Aduse-Poku, L., Palesh, O., & Hong, S. (2026). Rising Risk of Subsequent Primary Cancers Among US Cancer Survivors, 2000–2021. Cancer Medicine, 15(4). https://doi.org/10.1002/cam4.71778
Vancouver
Cheng HG, Aduse-Poku L, Palesh O, Hong S. Rising Risk of Subsequent Primary Cancers Among US Cancer Survivors, 2000–2021. Cancer Medicine. 2026;15(4). doi:10.1002/cam4.71778
BibTeX
@article{Cheng2026,
author = {Cheng, Hui G and Aduse-Poku, Livingstone and Palesh, Oxana and Hong, Susan},
title = {Rising Risk of Subsequent Primary Cancers Among US Cancer Survivors, 2000–2021},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {4},
doi = {10.1002/cam4.71778}
}
EUVIMED